Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 22645 | 318 | 27.4 | 59% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | RUFINAMIDE | Author keyword | 85 | 75% | 19% | 61 |
| 2 | CLOBAZAM | Author keyword | 33 | 45% | 18% | 56 |
| 3 | LENNOX GASTAUT SYNDROME | Author keyword | 23 | 29% | 21% | 67 |
| 4 | DROP SEIZURES | Author keyword | 11 | 78% | 2% | 7 |
| 5 | N DESMETHYLCLOBAZAM | Author keyword | 4 | 67% | 1% | 4 |
| 6 | N DESMETHYL CLOBAZAM | Author keyword | 3 | 100% | 1% | 3 |
| 7 | TOTAL SEIZURES | Author keyword | 3 | 100% | 1% | 3 |
| 8 | CLIN PHARMACOKINET DRUG SAFETY | Address | 2 | 67% | 1% | 2 |
| 9 | KLIN NEUROPADIATRIE NEUROL REHABIL | Address | 2 | 43% | 1% | 3 |
| 10 | PEDIAT NEUROSCI UNIT | Address | 1 | 50% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | RUFINAMIDE | 85 | 75% | 19% | 61 | Search RUFINAMIDE | Search RUFINAMIDE |
| 2 | CLOBAZAM | 33 | 45% | 18% | 56 | Search CLOBAZAM | Search CLOBAZAM |
| 3 | LENNOX GASTAUT SYNDROME | 23 | 29% | 21% | 67 | Search LENNOX+GASTAUT+SYNDROME | Search LENNOX+GASTAUT+SYNDROME |
| 4 | DROP SEIZURES | 11 | 78% | 2% | 7 | Search DROP+SEIZURES | Search DROP+SEIZURES |
| 5 | N DESMETHYLCLOBAZAM | 4 | 67% | 1% | 4 | Search N+DESMETHYLCLOBAZAM | Search N+DESMETHYLCLOBAZAM |
| 6 | N DESMETHYL CLOBAZAM | 3 | 100% | 1% | 3 | Search N+DESMETHYL+CLOBAZAM | Search N+DESMETHYL+CLOBAZAM |
| 7 | TOTAL SEIZURES | 3 | 100% | 1% | 3 | Search TOTAL+SEIZURES | Search TOTAL+SEIZURES |
| 8 | POST HOC ANALYSES | 1 | 50% | 1% | 2 | Search POST+HOC+ANALYSES | Search POST+HOC+ANALYSES |
| 9 | CLOXAZOLAM | 1 | 50% | 0% | 1 | Search CLOXAZOLAM | Search CLOXAZOLAM |
| 10 | CORPUS CALLOSTOMY | 1 | 50% | 0% | 1 | Search CORPUS+CALLOSTOMY | Search CORPUS+CALLOSTOMY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHILDHOOD EPILEPTIC ENCEPHALOPATHY | 15 | 68% | 4% | 13 |
| 2 | CONTROLLED PARTIAL SEIZURES | 15 | 88% | 2% | 7 |
| 3 | ADD ON RUFINAMIDE | 14 | 100% | 2% | 7 |
| 4 | N DESMETHYLCLOBAZAM | 13 | 61% | 4% | 14 |
| 5 | RUFINAMIDE | 7 | 57% | 3% | 8 |
| 6 | SLOW SPIKE WAVE | 6 | 41% | 3% | 11 |
| 7 | ADJUNCTIVE RUFINAMIDE | 3 | 100% | 1% | 3 |
| 8 | CLOBAZAM | 2 | 17% | 4% | 12 |
| 9 | 1 5 BENZODIAZEPINE CLOBAZAM | 1 | 100% | 1% | 2 |
| 10 | ATLANTA DEVELOPMENTAL DISABILITIES | 1 | 50% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Clobazam: A Newly Approved But Well-Established Drug for the Treatment of Intractable Epilepsy Syndromes | 2013 | 6 | 42 | 79% |
| Efficacy and safety of rufinamide in pediatric epilepsy | 2013 | 6 | 36 | 78% |
| Clobazam | 2007 | 38 | 43 | 88% |
| Experience in the use of clobazam in the treatment of Lennox-Gastaut syndrome | 2014 | 2 | 22 | 86% |
| Exposure to rufinamide and risks of CNS adverse events in drug-resistant epilepsy: a meta-analysis of randomized, placebo-controlled trials | 2014 | 2 | 16 | 81% |
| Long-Term Use of Clobazam in Lennox-Gastaut Syndrome: Experience in a Single Tertiary Epilepsy Center | 2013 | 3 | 19 | 89% |
| Rufinamide for Pediatric Patients with Lennox-Gastaut Syndrome A Comprehensive Overview | 2011 | 8 | 24 | 92% |
| Clobazam Therapeutic Drug Monitoring: A Comprehensive Review of the Literature With Proposals to Improve Future Studies | 2013 | 6 | 78 | 50% |
| RUFINAMIDE: A NOVEL BROAD-SPECTRUM ANTIEPILEPTIC DRUG | 2010 | 28 | 12 | 42% |
| Clobazam for patients with Lennox-Gastaut syndrome and epilepsy | 2012 | 5 | 71 | 68% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CLIN PHARMACOKINET DRUG SAFETY | 2 | 67% | 0.6% | 2 |
| 2 | KLIN NEUROPADIATRIE NEUROL REHABIL | 2 | 43% | 0.9% | 3 |
| 3 | PEDIAT NEUROSCI UNIT | 1 | 50% | 0.6% | 2 |
| 4 | ON KLIN VOGTAREUTH | 1 | 40% | 0.6% | 2 |
| 5 | CHILD FAMILIY HLTH SERV | 1 | 50% | 0.3% | 1 |
| 6 | CLIN NEUROL SCI EPILEPSY CLIN NEUROPHYSIOL | 1 | 50% | 0.3% | 1 |
| 7 | COCHRANE EPILEPSY GRP | 1 | 50% | 0.3% | 1 |
| 8 | EPILEPSIEKLIN KINDER JUGENDLICHE | 1 | 50% | 0.3% | 1 |
| 9 | EPILEPSIEZENTRUM KINDER JUGENDL | 1 | 50% | 0.3% | 1 |
| 10 | HOSP ROME | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000207843 | WEST SYNDROME//INFANTILE SPASMS//HYPSARRHYTHMIA |
| 2 | 0.0000200557 | LAMOTRIGINE//FELBAMATE//OXCARBAZEPINE |
| 3 | 0.0000198636 | LACOSAMIDE//ESLICARBAZEPINE ACETATE//PERAMPANEL |
| 4 | 0.0000124779 | DRAVET SYNDROME//SCN1A//GEFS |
| 5 | 0.0000097091 | 7 AMINOFLUNITRAZEPAM//BROMAZEPAM//FLUNITRAZEPAM |
| 6 | 0.0000096279 | TOPIRAMATE//TOPIRAMATE TOPAMAX//TOPIRAMATE TOXICITY |
| 7 | 0.0000087813 | ZONISAMIDE//NEUROSCI MOL BIOL//CA2 INDUCED CA2 RELEASING SYSTEM |
| 8 | 0.0000086247 | FIRST SEIZURE//SEIZURE RELAPSE//FIRST EPILEPTIC SEIZURE |
| 9 | 0.0000066409 | LEVETIRACETAM//SV2A//BRIVARACETAM |
| 10 | 0.0000065533 | KETOGENIC DIET//MODIFIED ATKINS DIET//JOHN M FREEMAN PEDIAT EPILEPSY |